Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mead Johnson Nutrition is a global leader in pediatric nutrition, best known for its flagship infant formula brand, Enfamil. The company specializes in the development and manufacture of infant formulas, toddler nutrition products, and specialized medical foods for children with metabolic disorders or severe food allergies. Founded in 1905, Mead Johnson has a long-standing reputation for scientific innovation, particularly in the inclusion of brain-building nutrients like DHA in its products. In 2017, the company was acquired by Reckitt for approximately $16.6 billion, integrating its nutritional expertise into Reckitt's global consumer health portfolio. Today, it continues to operate as a major division within Reckitt, focusing on clinical research to improve neonatal and pediatric health outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mead Johnson Nutrition.